Skip to main content
. 2023 May 12;5(1):vdad057. doi: 10.1093/noajnl/vdad057

Figure 2.

Figure 2.

(A) PFS analysis for patients undergoing GTR vs. STR. (B) PFS analysis by gender. (C) PFS analysis for patients by use of chemotherapy. (D) PFS analysis by use of radiation therapy.